Skip to content
Study details
Enrolling now

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Youssef Zeidan
NCT IDNCT06867484ClinicalTrials.gov data as of Apr 2026
Target enrollment

114

Study length

about 7.6 years

Ages

40+

Sex

Female only

Locations

2 sites in FL

What this study is about

This trial is testing the safety of treating breast cancer with re-radiation after a second surgery on the same side as before. The researchers want to see what effects, both good and bad, re-radiation has on people who have already received radiation treatment before surgery.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Receive Intensity modulated radiation therapy (IMRT)

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Rate of grade 3 or higher treatment-related adverse events (AEs)

Secondary: Distant metastasis-free survival (DMFS), Overall survival (OS)

Body systems

Oncology